Gf Fund Management Co. Ltd. Rhythm Pharmaceuticals, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,573 shares of RYTM stock, worth $97,510. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,573
Previous 1,290
21.94%
Holding current value
$97,510
Previous $72.2 Million
15.38%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RYTM
# of Institutions
245Shares Held
62.9MCall Options Held
403KPut Options Held
62.8K-
Black Rock Inc. New York, NY6.74MShares$418 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$377 Million6.69% of portfolio
-
Primecap Management CO Pasadena, CA5.79MShares$359 Million0.26% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$347 Million3.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$214 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.45B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...